Versant Ventures VI GP-GP, LLC insider trades: LENZ Therapeutics (LENZ) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Versant Ventures VI GP-GP, LLC reports to the SEC
and 6 more companies
Open-market buys and sales
35 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | LENZ | ↓ Sell | 132,944 | $46.01 | $6.1M | Direct | Oct 2, 2025 (2d) |
| Sep 30, 2025 | LENZ | ↓ Sell | 92,030 | $46.01 | $4.2M | Indirect | Oct 2, 2025 (2d) |
| Sep 19, 2025 | LVTX | ↓ Sell | 2,370,533 | $1.40 | $3.3M | Direct | Sep 23, 2025 (4d) |
| Sep 19, 2025 | LVTX | ↓ Sell | 532,870 | $1.40 | $747K | Indirect | Sep 23, 2025 (4d) |
| Sep 18, 2025 | LENZ | ↓ Sell | 90,654 | $42.23 | $3.8M | Direct | Sep 22, 2025 (4d) |
| Sep 18, 2025 | LENZ | ↓ Sell | 44,650 | $42.23 | $1.9M | Indirect | Sep 22, 2025 (4d) |
| Sep 18, 2025 | LVTX | ↓ Sell | 1,036,624 | $1.49 | $1.5M | Direct | Sep 18, 2025 (0d) |
| Sep 18, 2025 | LVTX | ↓ Sell | 647,810 | $1.49 | $962K | Indirect | Sep 18, 2025 (0d) |
| Aug 26, 2025 | LENZ | ↓ Sell | 126,023 | $39.47 | $5.0M | Direct | Aug 26, 2025 (0d) |
| Aug 26, 2025 | LENZ | ↓ Sell | 62,071 | $39.47 | $2.4M | Indirect | Aug 26, 2025 (0d) |
| Aug 18, 2025 | LENZ | ↓ Sell | 175,679 | $39.34 | $6.9M | Direct | Aug 19, 2025 (1d) |
| Aug 18, 2025 | LENZ | ↓ Sell | 85,034 | $39.33 | $3.3M | Indirect | Aug 19, 2025 (1d) |
| Jul 10, 2025 | LENZ | ↓ Sell | 191,376 | $34.00 | $6.5M | Direct | Jul 14, 2025 (4d) |
| Jun 27, 2025 | LENZ | ↓ Sell | 200,000 | $30.46 | $6.1M | Direct | Jul 1, 2025 (4d) |
| Jun 20, 2025 | LENZ | ↓ Sell | 200,877 | $30.15 | $6.1M | Indirect | Jun 20, 2025 (0d) |
| Jun 20, 2025 | LENZ | ↓ Sell | 133,924 | $30.25 | $4.1M | Direct | Jun 20, 2025 (0d) |
| Jun 10, 2025 | LENZ | ↓ Sell | 350,000 | $29.00 | $10.2M | Indirect | Jun 12, 2025 (2d) |
| Oct 29, 2024 | GLUE | ↓ Sell | 157,895 | $9.44 | $1.5M | Indirect | Oct 30, 2024 (1d) |
| Sep 20, 2024 | GLUE | ↓ Sell | 1,132,566 | $6.53 | $7.4M | Direct | Sep 24, 2024 (4d) |
| Sep 13, 2024 | GLUE | ↓ Sell | 567,213 | $6.00 | $3.4M | Direct | Sep 13, 2024 (0d) |
| Aug 12, 2024 | TPST | ↓ Sell | 787,999 | $1.23 | $967K | Direct | Aug 12, 2024 (0d) |
| Aug 9, 2022 | IPSC | ↓ Sell | 550,000 | $13.03 | $7.2M | Direct | Aug 11, 2022 (2d) |
| Jun 3, 2022 | RPTX | ↓ Sell | 750,000 | $12.25 | $9.2M | Indirect | Jun 7, 2022 (4d) |
| Oct 18, 2021 | OYST | ↓ Sell | 550,000 | $14.84 | $8.2M | Indirect | Oct 20, 2021 (2d) |
| Jun 29, 2021 | GRPH | ↑ Buy | 180,000 | $17.00 | $3.1M | Indirect | Jul 1, 2021 (2d) |
| Jun 28, 2021 | GLUE | ↑ Buy | 157,895 | $19.00 | $3.0M | By Versant Vantage I, L.P. | Jun 30, 2021 (2d) |
| Jun 22, 2021 | IPSC | ↑ Buy | 100,000 | $20.00 | $2.0M | Indirect | Jun 23, 2021 (1d) |
| Jun 23, 2020 | RPTX | ↑ Buy | 250,000 | $20.00 | $5.0M | Indirect | Jun 25, 2020 (2d) |
| Mar 3, 2020 | PASG | ↑ Buy | 225,000 | $18.00 | $4.0M | By Versant Vantage I, L.P. | Mar 3, 2020 (0d) |
| Jan 21, 2020 | AKRO | ↓ Sell | 59,532 | $20.87 | $1.2M | Indirect | Jan 21, 2020 (0d) |
| Jan 15, 2020 | AKRO | ↓ Sell | 50,837 | $20.04 | $1.0M | Indirect | Jan 15, 2020 (0d) |
| Jan 9, 2020 | AKRO | ↓ Sell | 53,057 | $19.99 | $1.1M | Indirect | Jan 9, 2020 (0d) |
| Jan 6, 2020 | AKRO | ↓ Sell | 72,444 | $19.70 | $1.4M | Indirect | Jan 6, 2020 (0d) |
| Nov 4, 2019 | OYST | ↑ Buy | 465,000 | $16.00 | $7.4M | Indirect | Nov 4, 2019 (0d) |
| Nov 4, 2019 | OYST | ↑ Buy | 125,000 | $16.00 | $2.0M | Direct | Nov 4, 2019 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LENZ insiders
Open-market trades in the last 12 months
About Versant Ventures VI GP-GP, LLC's insider trades
Versant Ventures VI GP-GP, LLC is an insider at LENZ Therapeutics (LENZ). Since Nov 4, 2019, it has reported 7 open-market purchases worth $26.6M and 28 sales worth $115.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (20 filings), conversions (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LENZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.